Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy
- PMID: 8671153
- DOI: 10.1093/oxfordjournals.humrep.a019031
Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy
Abstract
Recent progress in the diagnosis, pathophysiology, long-term ramifications and treatment of polycystic ovary syndrome has been rapid but the pathogenesis remains a challenging enigma and the treatment symptomatic. Objective ultrasound criteria for diagnosis are being formulated and have enabled an appreciation of the true prevalence and the associated clinical and biochemical manifestations. Although a heterogeneous syndrome, the final common pathway seems to involve a dysregulation of enzymes responsible for ovarian androgen biosynthesis, possibly influenced by insulin, growth factors and luteinizing hormone. A single gene defect, inherited in an autosomal dominant pattern, has been proposed. The treatment is necessarily symptomatic, depending on the needs of the patient. Long-term deleterious sequelae now emerging may demand suppression of the syndrome earlier in life. As the most prevalent cause of anovulatory infertility, a further elucidation of the basic pathogenesis is needed to allow the application of more specific and successful modalities of treatment.
Similar articles
-
[Polycystic ovary syndrome as a multisystemic endocrinopathy].Ceska Gynekol. 2000 Jul;65(4):260-8. Ceska Gynekol. 2000. PMID: 11039233 Review. Czech.
-
Polycystic ovary syndrome in adolescence.Ann N Y Acad Sci. 2008;1135:76-84. doi: 10.1196/annals.1429.005. Ann N Y Acad Sci. 2008. PMID: 18574211 Review.
-
Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.Panminerva Med. 2008 Dec;50(4):267-78. Panminerva Med. 2008. PMID: 19078868 Review.
-
Polycystic ovary syndrome: pathogenesis and treatment over the short and long term.Cleve Clin J Med. 2003 Jan;70(1):31-3, 36-41, 45. doi: 10.3949/ccjm.70.1.31. Cleve Clin J Med. 2003. PMID: 12549723 Review.
-
Polycystic ovary syndrome in obese adolescents.Curr Opin Endocrinol Diabetes Obes. 2008 Feb;15(1):30-6. doi: 10.1097/MED.0b013e3282f41d55. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18185060 Review.
Cited by
-
Impact of Bariatric Surgery on Female Reproductive Health and Maternal Outcomes.Obes Surg. 2020 Feb;30(2):383-390. doi: 10.1007/s11695-019-04245-0. Obes Surg. 2020. PMID: 31721063
-
Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT.Int J Reprod Biomed. 2016 Dec;14(12):743-754. Int J Reprod Biomed. 2016. PMID: 28331909 Free PMC article.
-
Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.J Endocrinol Invest. 2004 Apr;27(4):353-6. doi: 10.1007/BF03351061. J Endocrinol Invest. 2004. PMID: 15233555
-
Effect of Prebiotic Dietary Supplement Acacia senegal on Hormonal and Metabolic Markers in Polycystic Ovary Syndrome Patients: A Pilot Study.Cureus. 2023 Sep 18;15(9):e45480. doi: 10.7759/cureus.45480. eCollection 2023 Sep. Cureus. 2023. PMID: 37859871 Free PMC article.
-
EFFECT OF PROGESTERONE ON SURVIVAL, IN VITRO GROWTH AND IN VITRO MATURATION OF FOLLICLE DERIVED FROM MOUSE POLYCYSTIC OVARY.Acta Endocrinol (Buchar). 2018 Jul-Sep;14(3):307-314. doi: 10.4183/aeb.2018.307. Acta Endocrinol (Buchar). 2018. PMID: 31149276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
